Tang D - Search Results

1

Correction: circular RNA circATP9A promotes non-small cell Lung cancer progression by interacting with HuR and by promoting extracellular vesicles-mediated macrophage M2 polarization.

Yao Y, Chen C, Wang J, Xuan H, Chen X, Li Z, Yang F, Wang B, Lin S, Li S, Tang D, Gong L, Gao W. Yao Y, et al. Among authors: tang d. J Exp Clin Cancer Res. 2023 Dec 19;42(1):345. doi: 10.1186/s13046-023-02924-6. J Exp Clin Cancer Res. 2023. PMID: 38111017 Free PMC article. No abstract available.

2

P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer.

Tang D, Yue L, Yao R, Zhou L, Yang Y, Lu L, Gao W. Tang D, et al. Oncotarget. 2017 Apr 25;8(33):54548-54557. doi: 10.18632/oncotarget.17408. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903363 Free PMC article.

3

Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy.

Tang D, Yao R, Zhao D, Zhou L, Wu Y, Yang Y, Sun Y, Lu L, Gao W. Tang D, et al. Sci Rep. 2018 Mar 2;8(1):3917. doi: 10.1038/s41598-018-22257-1. Sci Rep. 2018. PMID: 29500455 Free PMC article.

4

Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.

Yang Y, Sun Y, Wu Y, Tang D, Ding X, Xu W, Su B, Gao W. Yang Y, et al. Among authors: tang d. Mol Carcinog. 2018 Jul;57(7):842-853. doi: 10.1002/mc.22805. Epub 2018 Apr 14. Mol Carcinog. 2018. PMID: 29566281

5

The miR-3127-5p/p-STAT3 axis up-regulates PD-L1 inducing chemoresistance in non-small-cell lung cancer.

Tang D, Zhao D, Wu Y, Yao R, Zhou L, Lu L, Gao W, Sun Y. Tang D, et al. J Cell Mol Med. 2018 Aug;22(8):3847-3856. doi: 10.1111/jcmm.13657. Epub 2018 May 4. J Cell Mol Med. 2018. PMID: 29726585 Free PMC article.

6

Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer.

Tang D, Zhao YC, Qian D, Liu H, Luo S, Patz EF, Moorman PG, Su L, Shen S, Christiani DC, Glass C, Gao W, Wei Q. Tang D, et al. Mol Carcinog. 2020 Jan;59(1):104-115. doi: 10.1002/mc.23132. Epub 2019 Nov 12. Mol Carcinog. 2020. PMID: 31713888 Free PMC article.

7

Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer.

Tang D, Zhao YC, Liu H, Luo S, Clarke JM, Glass C, Su L, Shen S, Christiani DC, Gao W, Wei Q. Tang D, et al. Int J Cancer. 2020 Sep 15;147(6):1559-1570. doi: 10.1002/ijc.32932. Epub 2020 Mar 9. Int J Cancer. 2020. PMID: 32072637 Free PMC article.

8

CCL25 promotes the migration and invasion of non-small cell lung cancer cells by regulating VEGF and MMPs in a CCR9-dependent manner.

Niu Y, Tang D, Fan L, Gao W, Lin H. Niu Y, et al. Among authors: tang d. Exp Ther Med. 2020 Jun;19(6):3571-3580. doi: 10.3892/etm.2020.8635. Epub 2020 Apr 2. Exp Ther Med. 2020. PMID: 32346420 Free PMC article.

9

Genetic variants of BIRC3 and NRG1 in the NLRP3 inflammasome pathway are associated with non-small cell lung cancer survival.

Tang D, Liu H, Zhao Y, Qian D, Luo S, Patz EF Jr, Su L, Shen S, ChristianI DC, Gao W, Wei Q. Tang D, et al. Am J Cancer Res. 2020 Aug 1;10(8):2582-2595. eCollection 2020. Am J Cancer Res. 2020. PMID: 32905523 Free PMC article.

10

The mechanism of ABL1 upregulating the expression of PD-L1 and the therapeutic effect of PD-L1 and STAT3 inhibitors in lung adenocarcinoma.

Tang D, Jiang H, Li Z, Gao W, Sun Y. Tang D, et al. Neoplasma. 2021 May;68(3):472-481. doi: 10.4149/neo_2020_200530N586. Epub 2020 Nov 5. Neoplasma. 2021. PMID: 33147049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,104 results

Search Page

Filters